Literature DB >> 35099377

Targeting the androgen receptor axis at the time of RP.

Alan I So1.   

Abstract

Entities:  

Year:  2021        PMID： 35099377      PMCID： PMC8418267          DOI： 10.5489/cuaj.7494

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  7 in total

1.  NCCN Guidelines Insights: Prostate Cancer, Version 1.2021.

Authors:  Edward Schaeffer; Sandy Srinivas; Emmanuel S Antonarakis; Andrew J Armstrong; Justin E Bekelman; Heather Cheng; Anthony Victor D'Amico; Brian J Davis; Neil Desai; Tanya Dorff; James A Eastham; Thomas A Farrington; Xin Gao; Eric Mark Horwitz; Joseph E Ippolito; Michael R Kuettel; Joshua M Lang; Rana McKay; Jesse McKenney; George Netto; David F Penson; Julio M Pow-Sang; Robert Reiter; Sylvia Richey; Mack Roach Iii; Stan Rosenfeld; Ahmad Shabsigh; Daniel E Spratt; Benjamin A Teply; Jonathan Tward; Dorothy A Shead; Deborah A Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2021-02-02       Impact factor: 11.908

2.  Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy.

Authors:  Edward M Messing; Judith Manola; Jorge Yao; Maureen Kiernan; David Crawford; George Wilding; P Anthony di'SantAgnese; Donald Trump
Journal:  Lancet Oncol       Date:  2006-06       Impact factor: 41.316

Review 3.  Do androgen-directed therapies improve outcomes in prostate cancer patients undergoing radical prostatectomy? A systematic review and meta-analysis.

Authors:  Ameeta L Nayak; Anathea S Flaman; Ranjeeta Mallick; Luke T Lavallée; Dean A Fergusson; Ilias Cagiannos; Chris Morash; Rodney H Breau
Journal:  Can Urol Assoc J       Date:  2021-01-08       Impact factor: 1.862

4.  Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer.

Authors:  Nancy L Keating; A James O'Malley; Matthew R Smith
Journal:  J Clin Oncol       Date:  2006-09-20       Impact factor: 44.544

5.  Natural history of progression after PSA elevation following radical prostatectomy.

Authors:  C R Pound; A W Partin; M A Eisenberger; D W Chan; J D Pearson; P C Walsh
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

6.  Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.

Authors:  Andrew J Stephenson; Peter T Scardino; James A Eastham; Fernando J Bianco; Zohar A Dotan; Paul A Fearn; Michael W Kattan
Journal:  J Natl Cancer Inst       Date:  2006-05-17       Impact factor: 13.506

Review 7.  Androgen deprivation therapy in nonmetastatic prostate cancer patients: Indications, treatment effects, and new predictive biomarkers.

Authors:  Dong Fang; Liqun Zhou
Journal:  Asia Pac J Clin Oncol       Date:  2019-02-06       Impact factor: 2.601
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.